This Week's Global Pharma News] Roche and Pfizer Receive US FDA Approvals, argenx Discontinues Phase 3 Trial, New ...
Researchers have fused an improved particle swarm optimization algorithm with simulated annealing to build a hybrid portfolio ...
This study systematically investigates intermittent large-amplitude oscillations across all three state variables of the memristive Hindmarsh–Rose neuron model. The large-amplitude excursions, arising ...
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for sys ...
AbbVie (NYSE: ABBV) today announced new research across its diverse dermatology portfolio to be presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress – October 3 in ...
For centuries, scientists have thought of the brain as a single, unified organ. But new research led by Stanford Medicine reveals that what we call the brain is two distinct organs that evolved ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
This is Minehisa from MISORAE.“The Head of [Function] (Sales, Development, HR) position is vacant, and we haven't been able ...
A comprehensive look at the safety data from the MARIPOSA-2 trial, including rates of adverse events, toxicities, and treatment modifications across the three regimens. Specific details are provided ...
CALGARY/HOUSTON/LONDON, Sept 17 (Reuters) - Partners in the Shell-led (SHEL.L), opens new tab LNG Canada export project could reach a final investment decision on its Phase 2 expansion as early as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results